SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 98 filers reported holding SERES THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122,425 | -50.3% | 51,439 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $246,393 | +15.5% | 51,439 | +36.7% | 0.00% | 0.0% |
| Q1 2023 | $213,289 | +19.3% | 37,617 | +17.8% | 0.00% | +100.0% |
| Q4 2022 | $178,814 | -27.8% | 31,931 | -17.2% | 0.00% | -50.0% |
| Q3 2022 | $247,664 | +510.7% | 38,577 | +226.3% | 0.00% | – |
| Q2 2022 | $40,556 | -85.7% | 11,824 | -70.2% | 0.00% | -100.0% |
| Q1 2022 | $282,977 | +33.0% | 39,744 | +55.6% | 0.00% | 0.0% |
| Q4 2021 | $212,748 | +137.8% | 25,540 | +98.7% | 0.00% | +100.0% |
| Q3 2021 | $89,464 | -85.3% | 12,854 | -49.5% | 0.00% | -83.3% |
| Q2 2021 | $607,412 | +36.3% | 25,468 | +17.7% | 0.01% | +50.0% |
| Q1 2021 | $445,650 | -20.1% | 21,644 | -5.0% | 0.00% | -33.3% |
| Q4 2020 | $558,012 | -13.5% | 22,776 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $644,789 | +494.0% | 22,776 | -0.1% | 0.01% | +600.0% |
| Q2 2020 | $108,557 | – | 22,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |